Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Papamichail

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Clinical and Experimental Immunology|February 1, 1987
Multiple sclerosis: I. Monocyte stimulatory defect in mixed lymphocyte reaction associated with clinical disease activityC N Baxevanis, G J Reclos, C Sfagos, et al.
Clinical and Experimental Immunology|November 1, 1987
Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosisG J Reclos, C N Baxevanis, C Sfagos, et al.
Haematology and Blood Transfusion|January 1, 1983
Poly(A)-polymerase levels in leukemiaM Papamichail, T Trangas, N Courtis, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1994
Induction of lymphokine-activated killer activity in mice by prothymosin alphaC N Baxevanis, A D Gritzapis, G V Dedoussis, et al.
Journal of Immunological Methods|December 28, 1994
An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometryN G Papadopoulos, G V Dedoussis, G Spanakos, et al.
Journal of Clinical Pathology|November 1, 1974
Immunological studies in a case of T-cell leukaemiaG Stathopoulos, M Papamichail, P Sheldon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumorC N Baxevanis, I F Voutsas, O E Tsitsilonis, et al.
Cancer|July 15, 1993
Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancerC N Baxevanis, G J Reclos, A D Gritzapis, et al.
Cancer|August 15, 1994
Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancerC N Baxevanis, G V Dedoussis, N G Papadopoulos, et al.
Hybridoma|December 1, 1995
Production and characterization of a monoclonal antibody against epirubicinN G Papadopoulos, A D Gritzapis, G V Dedoussis, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Immunology|February 1, 1987
Multiple sclerosis: I. Monocyte stimulatory defect in mixed lymphocyte reaction associated with clinical disease activityC N Baxevanis, G J Reclos, C Sfagos, et al.
Clinical and Experimental Immunology|November 1, 1987
Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosisG J Reclos, C N Baxevanis, C Sfagos, et al.
Haematology and Blood Transfusion|January 1, 1983
Poly(A)-polymerase levels in leukemiaM Papamichail, T Trangas, N Courtis, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1994
Induction of lymphokine-activated killer activity in mice by prothymosin alphaC N Baxevanis, A D Gritzapis, G V Dedoussis, et al.
Journal of Immunological Methods|December 28, 1994
An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometryN G Papadopoulos, G V Dedoussis, G Spanakos, et al.
Journal of Clinical Pathology|November 1, 1974
Immunological studies in a case of T-cell leukaemiaG Stathopoulos, M Papamichail, P Sheldon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumorC N Baxevanis, I F Voutsas, O E Tsitsilonis, et al.
Cancer|July 15, 1993
Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancerC N Baxevanis, G J Reclos, A D Gritzapis, et al.
Cancer|August 15, 1994
Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancerC N Baxevanis, G V Dedoussis, N G Papadopoulos, et al.
Hybridoma|December 1, 1995
Production and characterization of a monoclonal antibody against epirubicinN G Papadopoulos, A D Gritzapis, G V Dedoussis, et al.
Pageof 12